SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-170164
Filing Date
2022-06-08
Accepted
2022-06-08 16:01:10
Documents
5
Effectiveness Date
2022-06-08

Document Format Files

Seq Description Document Type Size
1 FORM S-8 d342266ds8.htm S-8 42028
2 EX-5.1 d342266dex51.htm EX-5.1 7278
3 EX-23.1 d342266dex231.htm EX-23.1 1677
4 EX-FILING FEES d342266dexfilingfees.htm EX-FILING FEES 13291
5 GRAPHIC g342266g0602042323501.jpg GRAPHIC 2534
  Complete submission text file 0001193125-22-170164.txt   69017
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: S-8 | Act: 33 | File No.: 333-265477 | Film No.: 221003456
SIC: 2836 Biological Products, (No Diagnostic Substances)